HEADER    PROTEIN FIBRIL                          17-JUL-17   5WHP              
TITLE     CRYSTAL STRUCTURE OF THE SEGMENT, NFGTFS, FROM THE A315T FAMILIAL     
TITLE    2 VARIANT OF THE LOW COMPLEXITY DOMAIN OF TDP-43, RESIDUES 312-317     
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: SEGMENT OF TAR DNA-BINDING PROTEIN 43;                     
COMPND   3 CHAIN: A;                                                            
COMPND   4 FRAGMENT: UNP RESIDUES 312-317;                                      
COMPND   5 SYNONYM: TDP-43;                                                     
COMPND   6 ENGINEERED: YES;                                                     
COMPND   7 MUTATION: YES                                                        
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 SYNTHETIC: YES;                                                      
SOURCE   3 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   4 ORGANISM_COMMON: HUMAN;                                              
SOURCE   5 ORGANISM_TAXID: 9606;                                                
SOURCE   6 OTHER_DETAILS: SYNTHETIC PEPTIDE NFGTFS CORRESPONDING TOSEGMENT 312- 
SOURCE   7 317 OF TDP-43                                                        
KEYWDS    AMYLOID, LARKS, TDP-43, PROTEIN FIBRIL                                
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    E.L.GUENTHER,M.R.SAWAYA,D.S.EISENBERG                                 
REVDAT   6   15-JAN-20 5WHP    1       REMARK                                   
REVDAT   5   18-DEC-19 5WHP    1       REMARK                                   
REVDAT   4   20-JUN-18 5WHP    1       JRNL                                     
REVDAT   3   06-JUN-18 5WHP    1       JRNL                                     
REVDAT   2   30-MAY-18 5WHP    1       JRNL                                     
REVDAT   1   23-MAY-18 5WHP    0                                                
JRNL        AUTH   E.L.GUENTHER,Q.CAO,H.TRINH,J.LU,M.R.SAWAYA,D.CASCIO,         
JRNL        AUTH 2 D.R.BOYER,J.A.RODRIGUEZ,M.P.HUGHES,D.S.EISENBERG             
JRNL        TITL   ATOMIC STRUCTURES OF TDP-43 LCD SEGMENTS AND INSIGHTS INTO   
JRNL        TITL 2 REVERSIBLE OR PATHOGENIC AGGREGATION.                        
JRNL        REF    NAT. STRUCT. MOL. BIOL.       V.  25   463 2018              
JRNL        REFN                   ESSN 1545-9985                               
JRNL        PMID   29786080                                                     
JRNL        DOI    10.1038/S41594-018-0064-2                                    
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.00 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : REFMAC 5.7.0032                                      
REMARK   3   AUTHORS     : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,              
REMARK   3               : NICHOLLS,WINN,LONG,VAGIN                             
REMARK   3                                                                      
REMARK   3    REFINEMENT TARGET : NULL                                          
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.00                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 15.22                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : 87.7                           
REMARK   3   NUMBER OF REFLECTIONS             : 1639                           
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
REMARK   3   R VALUE     (WORKING + TEST SET) : 0.087                           
REMARK   3   R VALUE            (WORKING SET) : 0.087                           
REMARK   3   FREE R VALUE                     : 0.093                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 10.000                          
REMARK   3   FREE R VALUE TEST SET COUNT      : 183                             
REMARK   3                                                                      
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
REMARK   3   TOTAL NUMBER OF BINS USED           : 20                           
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 1.00                         
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 1.03                         
REMARK   3   REFLECTION IN BIN     (WORKING SET) : 42                           
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 35.07                        
REMARK   3   BIN R VALUE           (WORKING SET) : 0.1320                       
REMARK   3   BIN FREE R VALUE SET COUNT          : 5                            
REMARK   3   BIN FREE R VALUE                    : 0.1870                       
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 48                                      
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 0                                       
REMARK   3   SOLVENT ATOMS            : 3                                       
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : 4.86                           
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 2.63                           
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : 0.19000                                              
REMARK   3    B22 (A**2) : 0.07000                                              
REMARK   3    B33 (A**2) : -0.23000                                             
REMARK   3    B12 (A**2) : 0.00000                                              
REMARK   3    B13 (A**2) : -0.17000                                             
REMARK   3    B23 (A**2) : 0.00000                                              
REMARK   3                                                                      
REMARK   3  ESTIMATED OVERALL COORDINATE ERROR.                                 
REMARK   3   ESU BASED ON R VALUE                            (A): 0.020         
REMARK   3   ESU BASED ON FREE R VALUE                       (A): 0.018         
REMARK   3   ESU BASED ON MAXIMUM LIKELIHOOD                 (A): 0.010         
REMARK   3   ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.436         
REMARK   3                                                                      
REMARK   3 CORRELATION COEFFICIENTS.                                            
REMARK   3   CORRELATION COEFFICIENT FO-FC      : 0.986                         
REMARK   3   CORRELATION COEFFICIENT FO-FC FREE : 0.983                         
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES        COUNT    RMS    WEIGHT      
REMARK   3   BOND LENGTHS REFINED ATOMS        (A):    49 ; 0.019 ; 0.020       
REMARK   3   BOND LENGTHS OTHERS               (A):    39 ; 0.001 ; 0.020       
REMARK   3   BOND ANGLES REFINED ATOMS   (DEGREES):    65 ; 1.790 ; 1.874       
REMARK   3   BOND ANGLES OTHERS          (DEGREES):    88 ; 0.687 ; 3.000       
REMARK   3   TORSION ANGLES, PERIOD 1    (DEGREES):     5 ; 4.212 ; 5.000       
REMARK   3   TORSION ANGLES, PERIOD 2    (DEGREES):     3 ;14.007 ;23.333       
REMARK   3   TORSION ANGLES, PERIOD 3    (DEGREES):     5 ; 8.865 ;15.000       
REMARK   3   TORSION ANGLES, PERIOD 4    (DEGREES):  NULL ;  NULL ;  NULL       
REMARK   3   CHIRAL-CENTER RESTRAINTS       (A**3):     6 ; 0.132 ; 0.200       
REMARK   3   GENERAL PLANES REFINED ATOMS      (A):    59 ; 0.009 ; 0.020       
REMARK   3   GENERAL PLANES OTHERS             (A):    17 ; 0.001 ; 0.020       
REMARK   3   NON-BONDED CONTACTS REFINED ATOMS (A):  NULL ;  NULL ;  NULL       
REMARK   3   NON-BONDED CONTACTS OTHERS        (A):  NULL ;  NULL ;  NULL       
REMARK   3   NON-BONDED TORSION REFINED ATOMS  (A):  NULL ;  NULL ;  NULL       
REMARK   3   NON-BONDED TORSION OTHERS         (A):  NULL ;  NULL ;  NULL       
REMARK   3   H-BOND (X...Y) REFINED ATOMS      (A):  NULL ;  NULL ;  NULL       
REMARK   3   H-BOND (X...Y) OTHERS             (A):  NULL ;  NULL ;  NULL       
REMARK   3   POTENTIAL METAL-ION REFINED ATOMS (A):  NULL ;  NULL ;  NULL       
REMARK   3   POTENTIAL METAL-ION OTHERS        (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY VDW REFINED ATOMS        (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY VDW OTHERS               (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY H-BOND REFINED ATOMS     (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY H-BOND OTHERS            (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY METAL-ION REFINED ATOMS  (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY METAL-ION OTHERS         (A):  NULL ;  NULL ;  NULL       
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.     COUNT   RMS    WEIGHT      
REMARK   3   MAIN-CHAIN BOND REFINED ATOMS  (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   MAIN-CHAIN BOND OTHER ATOMS    (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   MAIN-CHAIN ANGLE REFINED ATOMS (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   MAIN-CHAIN ANGLE OTHER ATOMS   (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SIDE-CHAIN BOND REFINED ATOMS  (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SIDE-CHAIN BOND OTHER ATOMS    (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SIDE-CHAIN ANGLE REFINED ATOMS (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SIDE-CHAIN ANGLE OTHER ATOMS   (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   LONG RANGE B REFINED ATOMS     (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   LONG RANGE B OTHER ATOMS       (A**2):  NULL ;  NULL ;  NULL       
REMARK   3                                                                      
REMARK   3 ANISOTROPIC THERMAL FACTOR RESTRAINTS.    COUNT   RMS   WEIGHT       
REMARK   3   RIGID-BOND RESTRAINTS          (A**2):    88 ; 5.773 ; 3.000       
REMARK   3   SPHERICITY; FREE ATOMS         (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SPHERICITY; BONDED ATOMS       (A**2):    90 ; 2.030 ; 5.000       
REMARK   3                                                                      
REMARK   3  NCS RESTRAINTS STATISTICS                                           
REMARK   3   NUMBER OF DIFFERENT NCS GROUPS : NULL                              
REMARK   3                                                                      
REMARK   3  TLS DETAILS                                                         
REMARK   3   NUMBER OF TLS GROUPS  : NULL                                       
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELLING.                                             
REMARK   3   METHOD USED : NULL                                                 
REMARK   3   PARAMETERS FOR MASK CALCULATION                                    
REMARK   3   VDW PROBE RADIUS   : 1.20                                          
REMARK   3   ION PROBE RADIUS   : 0.80                                          
REMARK   3   SHRINKAGE RADIUS   : 0.80                                          
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING   
REMARK   3  POSITIONS U VALUES : REFINED INDIVIDUALLY                           
REMARK   4                                                                      
REMARK   4 5WHP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-JUL-17.                  
REMARK 100 THE DEPOSITION ID IS D_1000229046.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 16-OCT-14                          
REMARK 200  TEMPERATURE           (KELVIN) : 100                                
REMARK 200  PH                             : 4.6                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : APS                                
REMARK 200  BEAMLINE                       : 24-ID-E                            
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.9791                             
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD                                
REMARK 200  DETECTOR MANUFACTURER          : ADSC QUANTUM 315                   
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : XDS                                
REMARK 200  DATA SCALING SOFTWARE          : XSCALE                             
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 1823                               
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.000                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 15.220                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : -3.000                             
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 87.6                               
REMARK 200  DATA REDUNDANCY                : 4.918                              
REMARK 200  R MERGE                    (I) : 0.08600                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 14.9700                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.00                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.03                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 37.0                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 2.84                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.10400                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 7.590                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO PHASING            
REMARK 200 SOFTWARE USED: SHELXD                                                
REMARK 200 STARTING MODEL: NULL                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): NULL                                      
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM SODIUM ACETATE 4.6, 200MM          
REMARK 280  AMMONIUM ACETATE, 30% PEG 4000, PH 4.6, VAPOR DIFFUSION, HANGING    
REMARK 280  DROP, TEMPERATURE 298K                                              
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1                         
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X,Y+1/2,-Z                                             
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.000000  1.000000  0.000000        2.42000            
REMARK 290   SMTRY3   2  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DECAMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350   BIOMT1   2  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   2  0.000000  1.000000  0.000000       -9.68000            
REMARK 350   BIOMT3   2  0.000000  0.000000  1.000000        0.00000            
REMARK 350   BIOMT1   3  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   3  0.000000  1.000000  0.000000       -4.84000            
REMARK 350   BIOMT3   3  0.000000  0.000000  1.000000        0.00000            
REMARK 350   BIOMT1   4  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   4  0.000000  1.000000  0.000000        4.84000            
REMARK 350   BIOMT3   4  0.000000  0.000000  1.000000        0.00000            
REMARK 350   BIOMT1   5  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   5  0.000000  1.000000  0.000000        9.68000            
REMARK 350   BIOMT3   5  0.000000  0.000000  1.000000        0.00000            
REMARK 350   BIOMT1   6 -1.000000  0.000000  0.000000       15.33000            
REMARK 350   BIOMT2   6  0.000000  1.000000  0.000000      -12.10000            
REMARK 350   BIOMT3   6  0.000000  0.000000 -1.000000        0.00000            
REMARK 350   BIOMT1   7 -1.000000  0.000000  0.000000       15.33000            
REMARK 350   BIOMT2   7  0.000000  1.000000  0.000000       -7.26000            
REMARK 350   BIOMT3   7  0.000000  0.000000 -1.000000        0.00000            
REMARK 350   BIOMT1   8 -1.000000  0.000000  0.000000       15.33000            
REMARK 350   BIOMT2   8  0.000000  1.000000  0.000000       -2.42000            
REMARK 350   BIOMT3   8  0.000000  0.000000 -1.000000        0.00000            
REMARK 350   BIOMT1   9 -1.000000  0.000000  0.000000       15.33000            
REMARK 350   BIOMT2   9  0.000000  1.000000  0.000000        2.42000            
REMARK 350   BIOMT3   9  0.000000  0.000000 -1.000000        0.00000            
REMARK 350   BIOMT1  10 -1.000000  0.000000  0.000000       15.33000            
REMARK 350   BIOMT2  10  0.000000  1.000000  0.000000        7.26000            
REMARK 350   BIOMT3  10  0.000000  0.000000 -1.000000        0.00000            
DBREF  5WHP A  312   317  UNP    Q13148   TADBP_HUMAN    312    317             
SEQADV 5WHP THR A  315  UNP  Q13148    ALA   315 ENGINEERED MUTATION            
SEQRES   1 A    6  ASN PHE GLY THR PHE SER                                      
FORMUL   2  HOH   *3(H2 O)                                                      
CRYST1   15.330    4.840   23.570  90.00  96.91  90.00 P 1 21 1      2          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.065232  0.000000  0.007904        0.00000                         
SCALE2      0.000000  0.206612  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.042737        0.00000                         
ATOM      1  N   ASN A 312       5.304  -1.135   9.814  1.00  2.00           N  
ANISOU    1  N   ASN A 312      253    253    253      0      0      0       N  
ATOM      2  CA  ASN A 312       6.110  -0.420   8.785  1.00  2.00           C  
ANISOU    2  CA  ASN A 312      253    253    253      0      0      0       C  
ATOM      3  C   ASN A 312       6.009  -1.152   7.462  1.00  2.00           C  
ANISOU    3  C   ASN A 312      253    253    253      0      0      0       C  
ATOM      4  O   ASN A 312       5.884  -2.379   7.402  1.00  2.00           O  
ANISOU    4  O   ASN A 312      253    253    253      0      0      0       O  
ATOM      5  CB  ASN A 312       7.575  -0.303   9.201  1.00  2.18           C  
ANISOU    5  CB  ASN A 312      253    312    261     -3      1    -21       C  
ATOM      6  CG  ASN A 312       7.792   0.820  10.222  1.00  2.27           C  
ANISOU    6  CG  ASN A 312      274    335    253    -41      1     -2       C  
ATOM      7  OD1 ASN A 312       6.837   1.361  10.745  1.00  2.24           O  
ANISOU    7  OD1 ASN A 312      312    267    271     28    -32    -15       O  
ATOM      8  ND2 ASN A 312       9.025   1.249  10.408  1.00  3.89           N  
ANISOU    8  ND2 ASN A 312      372    627    476    -48    -78   -201       N  
ATOM      9  N   PHE A 313       6.079  -0.357   6.390  1.00  2.00           N  
ANISOU    9  N   PHE A 313      253    253    253      0      0      0       N  
ATOM     10  CA  PHE A 313       6.055  -0.871   4.992  1.00  2.00           C  
ANISOU   10  CA  PHE A 313      253    253    253      0      0      0       C  
ATOM     11  C   PHE A 313       7.162  -0.164   4.236  1.00  2.00           C  
ANISOU   11  C   PHE A 313      253    253    253      0      0      0       C  
ATOM     12  O   PHE A 313       7.218   1.060   4.184  1.00  2.00           O  
ANISOU   12  O   PHE A 313      253    253    253      0      0      0       O  
ATOM     13  CB  PHE A 313       4.710  -0.522   4.365  1.00  2.00           C  
ANISOU   13  CB  PHE A 313      253    253    253      0      0      0       C  
ATOM     14  CG  PHE A 313       4.518  -1.086   2.962  1.00  2.00           C  
ANISOU   14  CG  PHE A 313      253    253    253      0      0      0       C  
ATOM     15  CD1 PHE A 313       5.188  -0.531   1.882  1.00  2.16           C  
ANISOU   15  CD1 PHE A 313      286    276    259    -27    -13     11       C  
ATOM     16  CD2 PHE A 313       3.670  -2.102   2.720  1.00  2.00           C  
ANISOU   16  CD2 PHE A 313      253    253    253      0      0      0       C  
ATOM     17  CE1 PHE A 313       5.006  -1.038   0.611  1.00  2.04           C  
ANISOU   17  CE1 PHE A 313      253    267    253      1      0      0       C  
ATOM     18  CE2 PHE A 313       3.483  -2.616   1.449  1.00  2.13           C  
ANISOU   18  CE2 PHE A 313      253    276    279      3     -3    -24       C  
ATOM     19  CZ  PHE A 313       4.169  -2.064   0.391  1.00  2.26           C  
ANISOU   19  CZ  PHE A 313      263    320    275     25    -15    -39       C  
ATOM     20  N   GLY A 314       8.090  -0.939   3.649  1.00  2.00           N  
ANISOU   20  N   GLY A 314      253    253    253      0      0      0       N  
ATOM     21  CA  GLY A 314       9.061  -0.327   2.785  1.00  2.00           C  
ANISOU   21  CA  GLY A 314      253    253    253      0      0      0       C  
ATOM     22  C   GLY A 314       9.997   0.666   3.465  1.00  2.00           C  
ANISOU   22  C   GLY A 314      253    253    253      0      0      0       C  
ATOM     23  O   GLY A 314      10.332   1.700   2.885  1.00  2.22           O  
ANISOU   23  O   GLY A 314      306    283    254    -39     -6      4       O  
ATOM     24  N   THR A 315      10.403   0.358   4.695  1.00  2.00           N  
ANISOU   24  N   THR A 315      253    253    253      0      0      0       N  
ATOM     25  CA  THR A 315      11.239   1.228   5.499  1.00  2.00           C  
ANISOU   25  CA  THR A 315      253    253    253      0      0      0       C  
ATOM     26  C   THR A 315      12.638   0.647   5.653  1.00  2.00           C  
ANISOU   26  C   THR A 315      253    253    253      0      0      0       C  
ATOM     27  O   THR A 315      12.838  -0.564   5.558  1.00  2.00           O  
ANISOU   27  O   THR A 315      253    253    253      0      0      0       O  
ATOM     28  CB  THR A 315      10.599   1.464   6.885  1.00  2.00           C  
ANISOU   28  CB  THR A 315      253    253    253      0      0      0       C  
ATOM     29  OG1 THR A 315      10.499   0.215   7.599  1.00  2.25           O  
ANISOU   29  OG1 THR A 315      314    271    267     33     29     16       O  
ATOM     30  CG2 THR A 315       9.207   2.070   6.805  1.00  2.00           C  
ANISOU   30  CG2 THR A 315      253    253    253      0      0      0       C  
ATOM     31  N   PHE A 316      13.556   1.548   5.996  1.00  2.00           N  
ANISOU   31  N   PHE A 316      253    253    253      0      0      0       N  
ATOM     32  CA  PHE A 316      14.967   1.228   6.175  1.00  2.00           C  
ANISOU   32  CA  PHE A 316      253    253    253      0      0      0       C  
ATOM     33  C   PHE A 316      15.435   1.817   7.493  1.00  2.00           C  
ANISOU   33  C   PHE A 316      253    253    253      0      0      0       C  
ATOM     34  O   PHE A 316      15.243   3.019   7.758  1.00  2.00           O  
ANISOU   34  O   PHE A 316      253    253    253      0      0      0       O  
ATOM     35  CB  PHE A 316      15.781   1.874   5.052  1.00  2.00           C  
ANISOU   35  CB  PHE A 316      253    253    253      0      0      0       C  
ATOM     36  CG  PHE A 316      15.415   1.323   3.703  1.00  2.00           C  
ANISOU   36  CG  PHE A 316      253    253    253      0      0      0       C  
ATOM     37  CD1 PHE A 316      14.326   1.809   3.002  1.00  2.00           C  
ANISOU   37  CD1 PHE A 316      253    253    253      0      0      0       C  
ATOM     38  CD2 PHE A 316      16.160   0.268   3.138  1.00  2.00           C  
ANISOU   38  CD2 PHE A 316      253    253    253      0      0      0       C  
ATOM     39  CE1 PHE A 316      13.955   1.254   1.791  1.00  2.10           C  
ANISOU   39  CE1 PHE A 316      253    278    264      0      0     17       C  
ATOM     40  CE2 PHE A 316      15.816  -0.258   1.905  1.00  2.16           C  
ANISOU   40  CE2 PHE A 316      282    257    281    -11     28    -11       C  
ATOM     41  CZ  PHE A 316      14.703   0.222   1.256  1.00  2.06           C  
ANISOU   41  CZ  PHE A 316      262    263    254     -9     -3      3       C  
ATOM     42  N   SER A 317      16.060   1.001   8.318  1.00  2.37           N  
ANISOU   42  N   SER A 317      350    256    293     16    -62    -10       N  
ATOM     43  CA  SER A 317      16.634   1.427   9.585  1.00  3.14           C  
ANISOU   43  CA  SER A 317      567    264    359    -59   -182     34       C  
ATOM     44  C   SER A 317      17.860   0.536   9.928  1.00  4.40           C  
ANISOU   44  C   SER A 317      682    550    439    138   -234    -52       C  
ATOM     45  O   SER A 317      18.163  -0.384   9.158  1.00  3.59           O  
ANISOU   45  O   SER A 317      297    520    546     81    -89    -49       O  
ATOM     46  CB  SER A 317      15.615   1.407  10.621  1.00  3.82           C  
ANISOU   46  CB  SER A 317      580    395    477    149   -101    -17       C  
ATOM     47  OG  SER A 317      15.110   0.163  10.861  1.00  5.20           O  
ANISOU   47  OG  SER A 317      839    649    487     96    121     26       O  
ATOM     48  OXT SER A 317      18.478   0.830  10.986  1.00  6.30           O  
ANISOU   48  OXT SER A 317      924    757    711    344   -418    -99       O  
TER      49      SER A 317                                                      
HETATM   50  O   HOH A 101      12.894   4.106   8.849  1.00  2.95           O  
ANISOU   50  O   HOH A 101      414    388    319    117    100     86       O  
HETATM   51  O   HOH A 102      18.494   1.760   6.921  1.00 36.25           O  
ANISOU   51  O   HOH A 102     3747   5204   4819   -522   -836    763       O  
HETATM   52  O   HOH A 103      12.085   1.756  10.018  1.00  5.06           O  
ANISOU   52  O   HOH A 103      731    725    466   -152      7    -15       O  
MASTER      254    0    0    0    0    0    0    6   51    1    0    1          
END                                                                             
